The TGA's Interim decision on CBD out today - referred to an expert advisory committee: ACMS out-of-session November 2014
The delegate's interim decision is
To include in Schedule 4
CANNABIDIOL in preparations for therapeutic use except when containing more than 2 per cent of other cannabinoids found in cannabis.
To amend the Schedule 9 entry for TETRAHYDROCANNABINOLS and their alkyl homologues exception (b) to:
when included in Schedule 4 and Schedule 8
The proposed implementation date is 1 June 2015.
CANNABIDIOL in preparations for therapeutic use except when containing more than 2 per cent of other cannabinoids found in cannabis.
To amend the Schedule 9 entry for TETRAHYDROCANNABINOLS and their alkyl homologues exception (b) to:
when included in Schedule 4 and Schedule 8
The proposed implementation date is 1 June 2015.
No comments:
Post a Comment